Differential association of S100A9, an inflammatory marker, and p53, a cell cycle marker, expression with epicardial adipocyte size in patients with cardiovascular disease.
about
S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy.Adipokines and their receptors: potential new targets in cardiovascular diseases.Investigating interactions between epicardial adipose tissue and cardiac myocytes: what can we learn from different approaches?S100A9 gene silencing inhibits the release of pro-inflammatory cytokines by blocking the IL-17 signalling pathway in mice with acute pancreatitis.S100A8/A9 in Inflammation.
P2860
Differential association of S100A9, an inflammatory marker, and p53, a cell cycle marker, expression with epicardial adipocyte size in patients with cardiovascular disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Differential association of S1 ...... s with cardiovascular disease.
@en
Differential association of S1 ...... s with cardiovascular disease.
@nl
type
label
Differential association of S1 ...... s with cardiovascular disease.
@en
Differential association of S1 ...... s with cardiovascular disease.
@nl
prefLabel
Differential association of S1 ...... s with cardiovascular disease.
@en
Differential association of S1 ...... s with cardiovascular disease.
@nl
P2093
P2860
P1433
P1476
Differential association of S1 ...... s with cardiovascular disease.
@en
P2093
José Ramón González-Juanatey
Juan Sierra
Rosa María Agra
Sonia Eiras
Ángel Fernández-Trasancos
P2860
P2888
P304
P356
10.1007/S10753-014-9876-3
P577
2014-10-01T00:00:00Z